QuickView for VAV1;jsessionid=C1A5597749F7F3859071E7D04EA174F9 (gene)

1. Vav1 accelerates Ras-driven lung cancer and modulates its tumor microenvironment.
2. Nanoparticles of VAV1 siRNA combined with LL37 peptide for the treatment of pancreatic cancer.
3. The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signaling in vivo and drives periph…
4. Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in pe…
5. Cancer-associated mutations in VAV1 trigger variegated signaling outputs and T-cell lymphomagenesis.

There were no clinical trials for VAV1;jsessionid=C1A5597749F7F3859071E7D04EA174F9